⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRM News
MEDIROM Healthcare Technologies Inc. American Depositary Share
MRMヘルスの主力候補品MH002、軽度から中等度の潰瘍性大腸炎の治療を対象に米FDAよりファストトラック指定を取得
businesswire.com
MRM
O principal candidato da MRM Health, MH002, recebe a designação de Fast Track (Via Rápida) da FDA dos EUA para o tratamento da colite ulcerativa leve a moderada
businesswire.com
MRM
MRM Health用于治疗轻度至中度溃疡性结肠炎的领先候选药物MH002被美国FDA授予快速通道资格
businesswire.com
MRM
MRM Health’s Lead Candidate MH002 Granted Fast Track Designation by U.S. FDA for the Treatment of Mild-to-Moderate Ulcerative Colitis
businesswire.com
MRM
WLRN anuncia la Sunshine Economy Summit: las principales voces del sur de Florida abordarán el crecimiento, la vivienda y el empleo USA - español USA - English USA - English
prnewswire.com
MRM
MEDIROM Launches Partnership with Tools for Humanity in February; Projects Approximately $39 Million in Income Before Income Taxes Over Two Years Following Expansion to 3,000 Nationwide Locations
globenewswire.com
MRM
MEDIROM Forms New Special Mission Team to Drive World ID Adoption Across 3,000 Locations Through Partnership with Tools for Humanity
globenewswire.com
MRM
MRM Health obtém aprovação da FDA para iniciar seu ensaio clínico de fase 2b do MH002 em colite ulcerativa leve a moderada
businesswire.com
MRM
MRMヘルス、軽度から中等度の潰瘍性大腸炎を対象としたMH002の後期第II相試験を開始すべくFDAのINDクリアランスを取得
businesswire.com
MRM
MRM Health获美国FDA新药临床试验申请(IND)批准，启动MH002治疗轻中度溃疡性结肠炎的2b期临床试验
businesswire.com
MRM